Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A A Gabizon

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cancer Investigation|June 19, 2001
Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapyA A Gabizon
Cancer Research|February 15, 1992
Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomesA A Gabizon
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2001
Stealth liposomes and tumor targeting: one step further in the quest for the magic bulletA A Gabizon
Hematology/Oncology Clinics of North America|April 1, 1994
Liposomal anthracyclinesA A Gabizon
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2001
Phase I study of doxil-cisplatin combination chemotherapy in patients with advanced malignanciesO Lyass, A Hubert, A A Gabizon
Pharmaceutical Research|May 1, 1993
Prolongation of the circulation time of doxorubicin encapsulated in liposomes containing a polyethylene glycol-derivatized phospholipid: pharmacokinetic studies in rodents and dogsA A Gabizon, Y Barenholz, M Bialer
Biochimica Et Biophysica Acta|August 24, 1992
In vitro cytotoxicity of liposome-encapsulated doxorubicin: dependence on liposome composition and drug releaseA T Horowitz, Y Barenholz, A A Gabizon
International Journal of Cancer|March 3, 1995
Reduction of the systemic toxicity of cisplatin by intra-arterial hepatic route administration for liver malignanciesA M Vexler, X Mou, A A Gabizon, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cancer Investigation|June 19, 2001
Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapyA A Gabizon
Cancer Research|February 15, 1992
Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomesA A Gabizon
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2001
Stealth liposomes and tumor targeting: one step further in the quest for the magic bulletA A Gabizon
Hematology/Oncology Clinics of North America|April 1, 1994
Liposomal anthracyclinesA A Gabizon
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2001
Phase I study of doxil-cisplatin combination chemotherapy in patients with advanced malignanciesO Lyass, A Hubert, A A Gabizon
Pharmaceutical Research|May 1, 1993
Prolongation of the circulation time of doxorubicin encapsulated in liposomes containing a polyethylene glycol-derivatized phospholipid: pharmacokinetic studies in rodents and dogsA A Gabizon, Y Barenholz, M Bialer
Biochimica Et Biophysica Acta|August 24, 1992
In vitro cytotoxicity of liposome-encapsulated doxorubicin: dependence on liposome composition and drug releaseA T Horowitz, Y Barenholz, A A Gabizon
International Journal of Cancer|March 3, 1995
Reduction of the systemic toxicity of cisplatin by intra-arterial hepatic route administration for liver malignanciesA M Vexler, X Mou, A A Gabizon, et al.
Pageof 1